FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980238250> ?p ?o ?g. }

• W2980238250 abstract "Abstract Abstract 2521 Purpose: The outcome for Teenagers and Young Adults (TYA) with T-cell Acute Lymphoblastic Leukaemia (T-ALL) has improved significantly using paediatric based chemotherapy protocols. Event free survival figures from the recently closed UKALL2003 highlight this observation. It remains poorly understood however why their outlook remains inferior to children aged 1 – 15 years whilst receiving identical treatment. Possible explanations for this phenomenon are distinct tumour biology, host factors and treatment adherence. The primary aim of this study is to characterise the tumour associated genetic events leading to TYA T-ALL and establish whether T-ALL in Teenagers and Young Adults is a distinct disease entity. The secondary aims are to identify new prognostic markers and potential targets to optimise therapy. Methods: DNA and RNA were extracted from 60 TYA T-ALL (15 – 25 years) historic samples. The DNA was derived from blasts at diagnosis or relapse, and matched with germ line DNA where available. The DNA was examined at high resolution for Copy Number Alterations (CNAs) and Loss of Heterozygosity (LOH) using the Affymetrix SNP6.0 platform and analysed by CNAG, dCHIP and Partek. The most frequent CNAs were confirmed by MLPA (P-383-T-ALL). In addition the DNA was screened for mutations in NOTCH1/FBXW7/PTEN using conventional Sanger sequencing and for mutations in NRAS, KRAS, CBL, FLT3 and SHP2 using denaturing high performance liquid chromatography. In cases without CDKN2A gene deletion we initially performed CDKN2A gene promoter methylation by SABiosciences EpiTect Methyl qPCR Arrays, followed up by Methylation Specific PCR (MSP). Where available, RNA was extracted from viable cells and the quality confirmed by Bioanalyser. Next the RNA was reverse transcribed to cDNA and subjected to real-time PCR gene expression analysis for CDKN2A and T-ALL related oncogenes. Results: The most frequent CNA was deletion of CDKN2A in 72.7% of patient samples (91.6% homozygous deletions). Other frequent CNAs were loss of MLLT3 (31%), STIL (27%), PTEN (19%), LEF1 (15%) and gain of MYB (12%). These CNAs were confirmed by MLPA. The STIL-TAL fusion occurred in 27% of patients. The only recurrent region of Copy Number Neutral LOH encompassed 9p24.3-p13.3, including the gene CDKN2A (27%). NOTCH1, FBXW7 and PTEN mutations occurred at expected frequencies. Rare mutations were identified in NRAS and CBL, and these mutations represented known variants. Bisulphite modified DNA was subjected to CDKN2A gene promoter methylation analysis. All samples examined were negative by Epitect Methyl Array, including the positive control cell line Raji. Promoter methylation was positive by MSP for the Raji cell line and some TYA T-ALL cases without CDKN2A gene deletion. Conclusions: This data identifies the frequency of recurrent mutations in T-ALL of Teenagers and Young Adults but reveals no striking differences with those observed in T-ALL in younger children. We are in the process of analysing additional cases to complete a total of 75 patients, including whole exome sequencing of a subset of cases. This sample size will allow us to detect genomic aberrations with a 5% incidence within this cohort (>90% probability) and to determine any prognostic significance. The most frequently observed aberration is CDKN2A gene deletion. In some cases without CDKN2A deletion we identified CDKN2A gene promoter methylation, offering an alternative mechanism of CDKN2A inactivation. To be able to appreciate potential cooperation between genetic abnormalities, we are correlating aberrant expression of the oncogenes TAL1, LYL1, LMO1, LMO2, TLX1, TLX3, NKX2, ERG and MEF2C with the genomic abnormalities identified. Disclosures: Gribben: Celgene: Honoraria; Roche: Honoraria; Merck: Honoraria; Mundipharma: Honoraria; Pharmacyclics: Honoraria." @default.
• W2980238250 created "2019-10-18" @default.
• W2980238250 creator A5004636845 @default.
• W2980238250 creator A5021664829 @default.
• W2980238250 creator A5024822816 @default.
• W2980238250 creator A5033884265 @default.
• W2980238250 creator A5036556487 @default.
• W2980238250 creator A5056507751 @default.
• W2980238250 creator A5060975195 @default.
• W2980238250 creator A5067154165 @default.
• W2980238250 creator A5067317405 @default.
• W2980238250 creator A5078487589 @default.
• W2980238250 creator A5088335384 @default.
• W2980238250 date "2012-11-16" @default.
• W2980238250 modified "2023-09-29" @default.
• W2980238250 title "Genetics of Teenage and Young Adult Acute Lymphoblastic T-Cell Leukaemia." @default.
• W2980238250 doi "https://doi.org/10.1182/blood.v120.21.2521.2521" @default.
• W2980238250 hasPublicationYear "2012" @default.
• W2980238250 type Work @default.
• W2980238250 sameAs 2980238250 @default.
• W2980238250 citedByCount "0" @default.
• W2980238250 crossrefType "journal-article" @default.
• W2980238250 hasAuthorship W2980238250A5004636845 @default.
• W2980238250 hasAuthorship W2980238250A5021664829 @default.
• W2980238250 hasAuthorship W2980238250A5024822816 @default.
• W2980238250 hasAuthorship W2980238250A5033884265 @default.
• W2980238250 hasAuthorship W2980238250A5036556487 @default.
• W2980238250 hasAuthorship W2980238250A5056507751 @default.
• W2980238250 hasAuthorship W2980238250A5060975195 @default.
• W2980238250 hasAuthorship W2980238250A5067154165 @default.
• W2980238250 hasAuthorship W2980238250A5067317405 @default.
• W2980238250 hasAuthorship W2980238250A5078487589 @default.
• W2980238250 hasAuthorship W2980238250A5088335384 @default.
• W2980238250 hasConcept C104317684 @default.
• W2980238250 hasConcept C120599132 @default.
• W2980238250 hasConcept C143589142 @default.
• W2980238250 hasConcept C143998085 @default.
• W2980238250 hasConcept C150194340 @default.
• W2980238250 hasConcept C180754005 @default.
• W2980238250 hasConcept C190283241 @default.
• W2980238250 hasConcept C190727270 @default.
• W2980238250 hasConcept C21790070 @default.
• W2980238250 hasConcept C2776053618 @default.
• W2980238250 hasConcept C2777609662 @default.
• W2980238250 hasConcept C2778461978 @default.
• W2980238250 hasConcept C2780265364 @default.
• W2980238250 hasConcept C2781107101 @default.
• W2980238250 hasConcept C2781187634 @default.
• W2980238250 hasConcept C2909962599 @default.
• W2980238250 hasConcept C36823959 @default.
• W2980238250 hasConcept C49105822 @default.
• W2980238250 hasConcept C501734568 @default.
• W2980238250 hasConcept C502942594 @default.
• W2980238250 hasConcept C54355233 @default.
• W2980238250 hasConcept C71924100 @default.
• W2980238250 hasConcept C76818968 @default.
• W2980238250 hasConcept C86554907 @default.
• W2980238250 hasConcept C86803240 @default.
• W2980238250 hasConceptScore W2980238250C104317684 @default.
• W2980238250 hasConceptScore W2980238250C120599132 @default.
• W2980238250 hasConceptScore W2980238250C143589142 @default.
• W2980238250 hasConceptScore W2980238250C143998085 @default.
• W2980238250 hasConceptScore W2980238250C150194340 @default.
• W2980238250 hasConceptScore W2980238250C180754005 @default.
• W2980238250 hasConceptScore W2980238250C190283241 @default.
• W2980238250 hasConceptScore W2980238250C190727270 @default.
• W2980238250 hasConceptScore W2980238250C21790070 @default.
• W2980238250 hasConceptScore W2980238250C2776053618 @default.
• W2980238250 hasConceptScore W2980238250C2777609662 @default.
• W2980238250 hasConceptScore W2980238250C2778461978 @default.
• W2980238250 hasConceptScore W2980238250C2780265364 @default.
• W2980238250 hasConceptScore W2980238250C2781107101 @default.
• W2980238250 hasConceptScore W2980238250C2781187634 @default.
• W2980238250 hasConceptScore W2980238250C2909962599 @default.
• W2980238250 hasConceptScore W2980238250C36823959 @default.
• W2980238250 hasConceptScore W2980238250C49105822 @default.
• W2980238250 hasConceptScore W2980238250C501734568 @default.
• W2980238250 hasConceptScore W2980238250C502942594 @default.
• W2980238250 hasConceptScore W2980238250C54355233 @default.
• W2980238250 hasConceptScore W2980238250C71924100 @default.
• W2980238250 hasConceptScore W2980238250C76818968 @default.
• W2980238250 hasConceptScore W2980238250C86554907 @default.
• W2980238250 hasConceptScore W2980238250C86803240 @default.
• W2980238250 hasLocation W29802382501 @default.
• W2980238250 hasOpenAccess W2980238250 @default.
• W2980238250 hasPrimaryLocation W29802382501 @default.
• W2980238250 hasRelatedWork W122607557 @default.
• W2980238250 hasRelatedWork W1503521084 @default.
• W2980238250 hasRelatedWork W1994256912 @default.
• W2980238250 hasRelatedWork W2022367820 @default.
• W2980238250 hasRelatedWork W2056639876 @default.
• W2980238250 hasRelatedWork W2077546113 @default.
• W2980238250 hasRelatedWork W2127211569 @default.
• W2980238250 hasRelatedWork W2391292032 @default.
• W2980238250 hasRelatedWork W2533209863 @default.
• W2980238250 hasRelatedWork W2552737367 @default.
• W2980238250 hasRelatedWork W2555515572 @default.
• W2980238250 hasRelatedWork W2566957807 @default.
• W2980238250 hasRelatedWork W2580819343 @default.
• W2980238250 hasRelatedWork W2588472739 @default.

• next